Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6758
Rank
A$0.96 B
Marketcap
A$48.39
Share price
-1.54%
Change (1 day)
-2.93%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$70.4 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are A$70.4 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$67.94 M18.48%
2023-12-31A$57.34 M